Molecular mechanisms of NF-κB activation induced by bacterial lipopolysaccharide through Toll-like receptors

Journal of Endotoxin Research

Volumn 6, Issue 6, 2000, Pages 453-457

  Zhang, Guolong ^a   Ghosh, Sankar ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BACTERIUM LIPOPOLYSACCHARIDE; CD14 ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4;

ANTISEPSIS; ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; DRUG DESIGN; DRUG EFFICACY; GENE ACTIVATION; HOST CELL; INFECTION; INFLAMMATORY DISEASE; MOLECULAR RECOGNITION; MOUSE; NONHUMAN; RECEPTOR BINDING; SEPTIC SHOCK; SIGNAL TRANSDUCTION;

ANIMALS; DROSOPHILA PROTEINS; HUMANS; INFLAMMATION MEDIATORS; LIPOPOLYSACCHARIDES; MEMBRANE GLYCOPROTEINS; MODELS, BIOLOGICAL; NF-KAPPA B; RECEPTORS, CELL SURFACE; SHOCK, SEPTIC; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4; TOLL-LIKE RECEPTORS;

BACTERIA (MICROORGANISMS);

EID: 0034450123     PISSN: 09680519     EISSN: None     Source Type: Journal    
DOI: 10.1177/09680519000060060701     Document Type: Article

References (35)

1. Pathogenetic mechanisms of septic shock
2. Search for sepsis drugs goes on despite past failures
3. Strategies for the treatment of sepsis
4. NF-kappa B and Rel proteins: Evolutionarily conserved mediators of immune responses
5. Signal transduction through NF-kappa B
6. CD14 and innate recognition of bacteria
7. Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin
8. Recognition of Gram-negative bacteria and endotoxin by the innate immune system
9. Signal transduction pathways activated by the IL-1 receptor family: Ancient signaling machinery in mammals, insects, and plants
10. Toll-receptor family and control of innate immunity
11. Toll signaling pathways in the innate immune response
12. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: Mutations in Tlr4 gene
13. Endotoxin-tolerant mice have mutations in Toll-like receptor 4
14. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: Evidence for TLR4 as the Lps gene product
15. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans
16. MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4
17. Regulatory roles for CD14 and phosphatidylinositol in the signaling via Toll-like receptor 4-MD-2
18. Transport of bacterial lipopolysaccharide to the Golgi apparatus
19. The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens
20. A conserved signaling pathway: The Drosophila Toll-dorsal pathway
21. Lipoproteins take their toll on the host
22. Cutting edge: Repurification of lipopolysaccharide eliminates signaling through both human and murine toll-like receptor 2
23. Restoration of lipopolysaccharide-mediated B-cell response after expression of a cDNA encoding a GTP-binding protein
24. Lps(d)/Ran of endotoxin-resistant C3H/HeJ mice is defective in mediating lipopolysaccharide endotoxin responses
25. Unresponsiveness of MyD88-deficient mice to endotoxin
26. IL-1 receptor-associated kinase modulates host responsiveness to endotoxin
27. TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling
28. The IKKbeta subunit of IkappaB kinase (IKK) is essential for nuclear factor kappaB activation and prevention of apoptosis
29. Severe liver degeneration and lack of NF-kappaB activation in NEMO/IKKgamma-deficient mice
30. Abnormal morphogenesis but intact IKK activation in mice lacking the IKKalpha subunit of IkappaB kinase
31. IRAK-M is a novel member of the Pelle/interleukin-1 receptor-associated kinase (IRAK) family
32. ECSIT is an evolutionarily conserved intermediate in the Toll/IL-1 signal transduction pathway
33. TAB2, a novel adaptor protein, mediates activation of TAK1 MAPK by linking TAK1 to TRAF6 in the IL-1 signal transduction pathway
34. T6BP, a TRAF6-interacting protein involved in IL-1 signaling
35. Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function